UPDATE: RBC Notes Avid Entered Current Good Manufacturing Practice Deal With Humanigen To Help Expand Production Capacity For Lenzilumab; RBC Notes Humanigen Data On Lenzilumab From Earlier Mon. Increases Chances Of Eventual FDA Approval